Adarx Pharmaceuticals, Inc. · NASDAQ:ADRX

BCLS Fund III Investments, LP reported a 6.30% stake in Adarx Pharmaceuticals, Inc. (Schedule 13G)

Event Sep 24, 2026 · Filed Oct 1, 2026

BCLS Fund III Investments, LP reported a 6.30% stake in Adarx Pharmaceuticals, Inc., 6,728,970 shares, as a passive investor on Sep 24, 2026. Filed Oct 1, 2026 (Schedule 13G).

Stake
6.30%
Shares
6,728,970
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BCLS Fund III Investments, LP6.30%6,728,970

Source

View original at SEC

Related